The Effect of L-Arginin Supplementation on lipid profiles in patients with diabetes type 2
Background & Objective: The prominent growth in the statistics of the patients with Diabetes Mellitus (DM) and the danger of its complication states a necessity to focus on finding new ways to control it. The present study then was performed to survey the effect of L-Arginin supplementation on...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | fas |
Published: |
Fasa University of Medical Sciences
2014-06-01
|
Series: | Journal of Fasa University of Medical Sciences |
Subjects: | |
Online Access: | http://journal.fums.ac.ir/browse.php?a_code=A-10-557-1&slc_lang=en&sid=1 |
id |
doaj-7c74bbec5dd9438880f7042514dd5982 |
---|---|
record_format |
Article |
spelling |
doaj-7c74bbec5dd9438880f7042514dd59822020-11-24T22:54:35ZfasFasa University of Medical SciencesJournal of Fasa University of Medical Sciences2228-51052228-73292014-06-014199110The Effect of L-Arginin Supplementation on lipid profiles in patients with diabetes type 2sara asadi0hasan mozaffari khosravi1MahnazMehdi Rahimi2Mohammad Mehdi Naghizadeh3 Fasa University of Medical Sciences Shahid Sadoughi University of Medical Sciences-Yazd Fasa University of Medical Sciences Shiraz University of Medical Science Background & Objective: The prominent growth in the statistics of the patients with Diabetes Mellitus (DM) and the danger of its complication states a necessity to focus on finding new ways to control it. The present study then was performed to survey the effect of L-Arginin supplementation on the metabolism of sugar and lipid profiles in patients with diabetes type 2. Materials & Methods: In a randomized double-blind clinical trial, 75 patients with diabetes type 2 were divided into three groupsrandomly: 1. 3 gr L-Arginin per day, 2. 6 gr L-Arginin per day and 3. The placebo group. Height, weight, waist, High Density Lipoprotein (HDL), Triglycerides (TG), Low Density ipoprotein (LDL), and the total cholesterol were measured before and after three months of intervention. Results: no significant change was made in any of the lipid parameters in the intervention group. However, the two means of cholesterol and LDL decreased from169.12±34.83 mg/dl to 142.08±32.13mg/dl(P-Value<0.001) and from 96.80±35.46mg/dl to 86.64±32.65(P-Value=0.001), respectively though The changes in TG and HDL were not significant. Conclusion: Daily consumption of six gram L-Arginin during three months improves the lipid profiles in patients with Diabetes type2. Nevertheless, the dosage of three gram in a day of this supplement has no effect on the blood lipids status. http://journal.fums.ac.ir/browse.php?a_code=A-10-557-1&slc_lang=en&sid=1Garlic lead kidney rat. |
collection |
DOAJ |
language |
fas |
format |
Article |
sources |
DOAJ |
author |
sara asadi hasan mozaffari khosravi MahnazMehdi Rahimi Mohammad Mehdi Naghizadeh |
spellingShingle |
sara asadi hasan mozaffari khosravi MahnazMehdi Rahimi Mohammad Mehdi Naghizadeh The Effect of L-Arginin Supplementation on lipid profiles in patients with diabetes type 2 Journal of Fasa University of Medical Sciences Garlic lead kidney rat. |
author_facet |
sara asadi hasan mozaffari khosravi MahnazMehdi Rahimi Mohammad Mehdi Naghizadeh |
author_sort |
sara asadi |
title |
The Effect of L-Arginin Supplementation on lipid profiles in patients with diabetes type 2 |
title_short |
The Effect of L-Arginin Supplementation on lipid profiles in patients with diabetes type 2 |
title_full |
The Effect of L-Arginin Supplementation on lipid profiles in patients with diabetes type 2 |
title_fullStr |
The Effect of L-Arginin Supplementation on lipid profiles in patients with diabetes type 2 |
title_full_unstemmed |
The Effect of L-Arginin Supplementation on lipid profiles in patients with diabetes type 2 |
title_sort |
effect of l-arginin supplementation on lipid profiles in patients with diabetes type 2 |
publisher |
Fasa University of Medical Sciences |
series |
Journal of Fasa University of Medical Sciences |
issn |
2228-5105 2228-7329 |
publishDate |
2014-06-01 |
description |
Background & Objective: The prominent growth in the statistics of the patients with Diabetes Mellitus (DM) and the danger of its complication states a necessity to focus on finding new ways to control it. The present study then was performed to survey the effect of L-Arginin supplementation on the metabolism of sugar and lipid profiles in patients with diabetes type 2.
Materials & Methods: In a randomized double-blind clinical trial, 75 patients with diabetes type 2 were divided into three groupsrandomly: 1. 3 gr L-Arginin per day, 2. 6 gr L-Arginin per day and 3. The placebo group. Height, weight, waist, High Density Lipoprotein (HDL), Triglycerides (TG), Low Density ipoprotein (LDL), and the total cholesterol were measured before and after three months of intervention.
Results: no significant change was made in any of the lipid parameters in the intervention group. However, the two means of cholesterol and LDL decreased from169.12±34.83 mg/dl to 142.08±32.13mg/dl(P-Value<0.001) and from 96.80±35.46mg/dl to 86.64±32.65(P-Value=0.001), respectively though The changes in TG and HDL were not significant.
Conclusion: Daily consumption of six gram L-Arginin during three months improves the lipid profiles in patients with Diabetes type2. Nevertheless, the dosage of three gram in a day of this supplement has no effect on the blood lipids status.
|
topic |
Garlic lead kidney rat. |
url |
http://journal.fums.ac.ir/browse.php?a_code=A-10-557-1&slc_lang=en&sid=1 |
work_keys_str_mv |
AT saraasadi theeffectoflargininsupplementationonlipidprofilesinpatientswithdiabetestype2 AT hasanmozaffarikhosravi theeffectoflargininsupplementationonlipidprofilesinpatientswithdiabetestype2 AT mahnazmehdirahimi theeffectoflargininsupplementationonlipidprofilesinpatientswithdiabetestype2 AT mohammadmehdinaghizadeh theeffectoflargininsupplementationonlipidprofilesinpatientswithdiabetestype2 AT saraasadi effectoflargininsupplementationonlipidprofilesinpatientswithdiabetestype2 AT hasanmozaffarikhosravi effectoflargininsupplementationonlipidprofilesinpatientswithdiabetestype2 AT mahnazmehdirahimi effectoflargininsupplementationonlipidprofilesinpatientswithdiabetestype2 AT mohammadmehdinaghizadeh effectoflargininsupplementationonlipidprofilesinpatientswithdiabetestype2 |
_version_ |
1725658925897875456 |